HR Execs on the Move

Hillcroft Medical Clinic Assn

www.hillcroftmed.com

 
Hillcroft Medical Clinic Assn is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Houston, TX. To find more information about Hillcroft Medical Clinic Assn, please visit www.hillcroftmed.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

JRNI Coaching

JRNI Coaching provides authentic life coach training and certification in a real community with expert instructors. Join the life coaching revolution today!

Ulrich Medical Concepts

Ulrich Medical Concepts is a Paducah, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blakehurst

Blakehurst Retirement Community is a life plan community in the Baltimore area that offers a range of residential options and amenities designed to contribute to residents’ overall happiness and well-being. They specialize in senior living communities ...

Hu-Friedy

Founded in 1908, Hu-Friedy has since become a world leader in dental instrument manufacturing. Today, we take a broader view of the value we offer our customers. We are focused on delivering the highest quality product, service, and community experience in the dental industry in order to help dental professionals perform at their best. Our 10,000 dental instruments and product solutions are sold in over 100 countries, and we have more than 600 employees representing and growing our brand around the world. Headquartered in Chicago, we have offices and distribution centers in the Netherlands, Italy, Germany, China, and Japan, and a sales force spread over 30 different countries.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.